| Entry |
|
|---|
| Name |
Betovumeline (USAN/INN) |
|---|
| Formula |
C8H11N3O
|
|---|
| Exact mass |
165.0902
|
|---|
| Mol weight |
165.19
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01490 Muscarinic cholinergic receptor agonist
|
|---|
| Efficacy |
Muscarinic acetylcholine receptor agonist |
|---|
| Comment |
Treatment of multiple diseases of the central nervous system, including Alzheimer's disease psychosis, schizophrenia, and dyskinesias.
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01490 Muscarinic cholinergic receptor agonist
D13252 Betovumeline
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM1
D13252 Betovumeline (USAN/INN)
CHRM4
D13252 Betovumeline (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 12
1 N1x N 17.1396 -13.7957
2 C1x C 16.0094 -14.6029
3 C1y C 16.4279 -15.9273
4 C1z C 17.8168 -15.9385
5 C1x C 18.2565 -14.6210
6 C1x C 17.2416 -17.2026
7 C8y C 19.1867 -16.1667
8 N5x N 19.8104 -17.4156
9 C8y C 21.1909 -17.2083
10 N5x N 21.4203 -15.8313
11 O2x O 20.1817 -15.1877
12 C1a C 22.1705 -18.2039
BOND 14
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 4 6 1
7 3 6 1
8 4 7 1 #Down
9 7 8 2
10 8 9 1
11 9 10 2
12 10 11 1
13 7 11 1
14 9 12 1
|
|---|
